Challenging Weight-Tiered Antibiotic Prophylaxis in Obese Patients Undergoing Colorectal Surgery Using CT-Derived...

Area of Science:

• Pharmacokinetics and pharmacodynamics
• Obesity medicine
• Surgical prophylaxis

Background:

• Current cefazolin dosing guidelines for patients weighing ≥120 kg may not optimize antibiotic distribution.
• Body weight alone is an inconsistent predictor of cefazolin concentration at the surgical site in obese individuals.

Purpose of the Study:

• To evaluate if CT-derived body composition and kidney function predict cefazolin concentrations better than body weight in obese patients undergoing colorectal surgery.
• To refine cefazolin dosing strategies for improved surgical site infection (SSI) prevention.

Main Methods:

• Prospective study involving obese patients undergoing colorectal surgery receiving cefazolin prophylaxis.
• Preoperative CT imaging to derive body composition metrics (e.g., subcutaneous fat area).
• Measurement of cefazolin concentrations in plasma and surgical tissues; modeling to identify predictors of target attainment.

Main Results:

• Subcutaneous fat area (SFA) and creatinine clearance (CLcr) were key predictors of cefazolin tissue exposure and elimination.
• Current weight-based dosing achieved 78%-84% target attainment.
• A revised framework using SFA and CLcr identified an additional 10%-14% of patients needing dose adjustment, improving SSI risk identification.

Conclusions:

• Cefazolin exposure in obese patients is more accurately predicted by local adiposity (SFA) and kidney function (CLcr) than by current weight-based dosing thresholds.
• Revised dosing criteria enhance the identification of patients at risk for underdosing and SSI without increasing overall antibiotic use.